Hindustan Bio Sciences Ltd. (HINDBIO.BO)
-BSE 1.02 0.00(0.00%) Jun 11, 2:46AM EDT
| Prev Close: | 1.02 |
|---|
| Open: | 1.02 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.02 - 1.02 |
|---|
| 52wk Range: | 0.91 - 2.03 |
|---|
| Volume: | 150 |
|---|
| Avg Vol (3m): | 368 |
|---|
| Market Cap: | 9.94M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in INR.
Headlines
- No Headlines available for HINDBIO.BO at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.26 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Hindustan Bio Sciences Limited engages in the import and marketing of recombinant human erythropoietin in India. It offers its products under the brand names of EPOVIN, EPOSINO, TRANSFER & NEPHRODIL, and EPOREC.
View More 
0.64%